Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pa 19104-4399, USA.
J Thorac Cardiovasc Surg. 2011 Jul;142(1):106-12. doi: 10.1016/j.jtcvs.2010.10.033. Epub 2011 Jan 26.
To determine the incidence, risk factors, and outcomes after early, unplanned intervention on systemic-to-pulmonary artery shunts in neonates.
We retrospectively studied all neonates undergoing systemic-to-pulmonary artery shunt placement at The Children's Hospital of Philadelphia between September 1, 2002, and May 1, 2005. Patients requiring transcatheter or surgical systemic-to-pulmonary artery shunt intervention before discharge were compared with those not undergoing shunt intervention.
A total of 206 patients underwent shunt placement. Diagnoses included hypoplastic left heart syndrome (62.1%), pulmonary atresia (15%), tricuspid atresia (4.9%), tetralogy of Fallot (2.4%), and other lesions with obstruction to systemic (10.7%) or pulmonary blood flow (4.9%). Twenty-one interventions occurred in 20 patients (9.7%). Risk factors for intervention included heterotaxy syndrome (P = .04), congenital abnormality (P = .04), and a trend toward lower birthweight. In patients with a modified Blalock-Taussig shunt, similar risk factors were identified and the incidence of intervention decreased with increasing shunt size. In-hospital mortality was 30% (6/20) for the cases and 8.1% (15/186) for the nonintervention group (P = .02). Long-term survival was significantly lower in patients requiring intervention (P = .002). This group also had a higher incidence of infections (P < .001) and extracorporeal membrane oxygenation (P < .001), and longer hospital stay (P = .001).
In neonates undergoing systemic-to-pulmonary artery shunt placement, approximately 10% underwent shunt intervention before discharge. Some factors, such as low birthweight, shunt size, noncardiac congenital abnormalities, and heterotaxy syndrome, may help identify patients at risk. Patients undergoing intervention experienced increased morbidity and mortality.
确定新生儿体内至肺动脉分流术早期、计划外干预的发生率、风险因素和结果。
我们回顾性研究了 2002 年 9 月 1 日至 2005 年 5 月 1 日期间在费城儿童医院接受体内至肺动脉分流术的所有新生儿。将需要在出院前进行经导管或手术体内至肺动脉分流术干预的患者与未进行分流术干预的患者进行比较。
共有 206 例患者接受了分流术。诊断包括左心发育不全综合征(62.1%)、肺动脉闭锁(15%)、三尖瓣闭锁(4.9%)、法洛四联症(2.4%)和其他系统或肺血流阻塞病变(10.7%)。20 名患者中有 21 名接受了干预(9.7%)。干预的危险因素包括异构综合征(P=0.04)、先天性异常(P=0.04)和出生体重较低的趋势。在接受改良 Blalock-Taussig 分流术的患者中,也发现了类似的危险因素,并且随着分流器尺寸的增加,干预的发生率降低。住院死亡率为干预组 30%(6/20),非干预组 8.1%(15/186)(P=0.02)。需要干预的患者的长期生存率明显较低(P=0.002)。该组还具有更高的感染发生率(P<0.001)、体外膜氧合(P<0.001)和更长的住院时间(P=0.001)。
在接受体内至肺动脉分流术的新生儿中,约 10%在出院前接受了分流术干预。一些因素,如低出生体重、分流器尺寸、非心脏先天性异常和异构综合征,可能有助于识别高危患者。接受干预的患者经历了更高的发病率和死亡率。